Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
18,878,833
-
Share change
-
+3,727,014
-
Total reported value
-
$1,126,182,384
-
Put/Call ratio
-
90%
-
Price per share
-
$59.66
-
Number of holders
-
207
-
Value change
-
+$220,571,922
-
Number of buys
-
122
-
Number of sells
-
73
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2024
As of 30 Sep 2024,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
207 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,878,833 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Ranger Investment Management, L.P., Pacer Advisors, Inc., JPMORGAN CHASE & CO, Global Alpha Capital Management Ltd., and CITADEL ADVISORS LLC.
This page lists
207
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.